Precigen, Inc. (PGEN)
4.73
+0.26
(+5.82%)
USD |
NASDAQ |
Nov 09, 16:00
4.65
-0.08
(-1.69%)
Pre-Market: 09:21
Precigen Cash and Short Term Investments (Quarterly) : 46.07M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 46.07M |
| June 30, 2026 | 38.21M |
| March 31, 2026 | 56.25M |
| December 31, 2025 | 97.86M |
| September 30, 2025 | 121.14M |
| June 30, 2025 | 59.75M |
| March 31, 2025 | 80.24M |
| December 31, 2024 | 97.91M |
| September 30, 2024 | 28.63M |
| June 30, 2024 | 19.54M |
| March 31, 2024 | 44.76M |
| December 31, 2023 | 62.86M |
| September 30, 2023 | 73.76M |
| June 30, 2023 | 88.43M |
| March 31, 2023 | 117.89M |
| December 31, 2022 | 99.29M |
| September 30, 2022 | 153.77M |
| June 30, 2022 | 115.30M |
| March 31, 2022 | 112.14M |
| December 31, 2021 | 108.66M |
| September 30, 2021 | 114.41M |
| June 30, 2021 | 115.11M |
| March 31, 2021 | 105.69M |
| December 31, 2020 | 100.12M |
| September 30, 2020 | 113.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 133.00M |
| March 31, 2020 | 149.17M |
| December 31, 2019 | 75.05M |
| September 30, 2019 | 106.03M |
| June 30, 2019 | 125.80M |
| March 31, 2019 | 181.82M |
| December 31, 2018 | 223.86M |
| September 30, 2018 | 254.28M |
| June 30, 2018 | 88.12M |
| March 31, 2018 | 130.49M |
| December 31, 2017 | 86.66M |
| September 30, 2017 | 115.70M |
| June 30, 2017 | 164.15M |
| March 31, 2017 | 212.22M |
| December 31, 2016 | 244.20M |
| September 30, 2016 | 243.53M |
| June 30, 2016 | 270.75M |
| March 31, 2016 | 260.39M |
| December 31, 2015 | 238.31M |
| September 30, 2015 | 216.30M |
| June 30, 2015 | 166.33M |
| March 31, 2015 | 181.48M |
| December 31, 2014 | 115.96M |
| September 30, 2014 | 123.08M |
| June 30, 2014 | 175.55M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 44.96M |
| Aldeyra Therapeutics, Inc. | 40.98M |
| Repligen Corp. | 865.03M |
| AC Immune SA | 93.42M |
| Inovio Pharmaceuticals, Inc. | 36.67M |